No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human ING5 Antibodies:
anti-Mouse (Murine) ING5 Antibodies:
anti-Rat (Rattus) ING5 Antibodies:
Go to our pre-filtered search.
Human Polyclonal ING5 Primary Antibody for IF, WB - ABIN529644
Voss, Collin, Dixon, Thomas: Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity. in Developmental cell 2009
Show all 3 Pubmed References
Human Polyclonal ING5 Primary Antibody for ELISA, WB - ABIN129552
Iizuka, Sarmento, Sekiya, Scrable, Allis, Smith: Hbo1 Links p53-dependent stress signaling to DNA replication licensing. in Molecular and cellular biology 2007
The Hepatitis B virus X protein (HBx) downregulates the expression of the miR-181b target gene ING5, resulting in the promotion of HCC cell proliferation.
our results demonstrate, for the first time that overexpression of ING5 in osteosarcoma cells induces apoptosis
ING5 promotes brain tumor initiating cells stemness by maintaining intracellular calcium levels and activating the follicle stimulating hormone pathway.
Nucleocytoplasmic translocation of ING5 protein occurs in breast cancer, and the high expression of nuclear ING5 is inversely related to some poor clinicopathological behaviors of breast cancer.
Overexpression of ING5 inhibited cell proliferation, neoplasm invasion and epithelial-mesenchymal transition of thyroid cancer cells.
We revealed that miR-24 had the opposite effects to those of ING5 on breast cancer cells and could accelerate xenografted tumor growth in vivo. Our findings uncover the tumor-suppressive role of ING5 and the regulatory pathway of ING5 in breast cancer and may provide insights into the molecular mechanisms of breast carcinogenesis
ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-kappaB/MMP-9 signaling pathway.
Data suggest that inhibitor of growth protein 5 (ING5) downregulation might involved in carcinogenesis, growth, and invasion of lung cancer and could be considered as a promising marker to gauge the aggressiveness of lung cancer.
miR-1307 could promote ovarian cancer chemoresistance by targeting the ING5 expression and miR-1307 might serve as a therapeutic target for ovarian cancer.
miR-331-3p is upregulated by HBV and promotes proliferation of hepatocellular carcinoma cells though repression of ING5 expression.
Suggest that ING5 expression might be a good marker for gastric carcinogenesis and its subsequent progression by inhibiting proliferation, growth, migration, invasion and metastasis.
Loss of ING5 expression is associated with lung cancer.
Identified ING5 as a novel CDK2 substrate. ING5 is phosphorylated at a single site, threonine 152, by cyclin E/CDK2 and cyclin A/CDK2. This site is also phosphorylated in cells in a cell cycle dependent manner, consistent with it being a CDK2 substrate.
Results showed that ING5 gene expression is inhibited by miR-193a-3p and is instrumental in miR-193a-3p's role in activating BCa chemoresistance.
Data indicate that ING5 associates with Tip60 (KAT5) to form a complex with p53.
ING5 down-regulation promotes bone mesenchymal stem cell proliferation.
Results indicate that ING5 is a growth suppressor with suppressed expression in AML whose functions depend on its interaction with INCA1.
EBNA3C negatively regulate p53-mediated functions by interacting with ING4 and ING5.
Aberrant inhibitor of growth 5 expression may contribute to pathogenesis, growth, and invasion of colorectal carcinomas.
). Survival analysis indicated that nuclear ING5 was closely linked to favorable prognosis of carcinoma patients (P < .05), albeit not independent.
The protein encoded by this gene is similar to ING1, a tumor suppressor protein that can interact with TP53, inhibit cell growth, and induce apoptosis. This protein contains a PHD-finger, which is a common motif in proteins involved in chromatin remodeling. This protein can bind TP53 and EP300/p300, a component of the histone acetyl transferase complex, suggesting its involvement in TP53-dependent regulatory pathway.
inhibitor of growth protein 5
, inhibitor of growth family, member 5
, inhibitor of growth
, tumor suppressor